Mindfulness-Based Relapse Prevention to Improve Medication Assisted Treatment Adherence and Drug-use Outcomes for Opioid Use Disorder

NACompletedINTERVENTIONAL
Enrollment

105

Participants

Timeline

Start Date

August 1, 2021

Primary Completion Date

August 20, 2024

Study Completion Date

August 20, 2024

Conditions
Opioid-use Disorder
Interventions
BEHAVIORAL

Mindfulness-Based Relapse Prevention - Rolling Admission (MBRP-RA)

Integrates evidenced-based practices to decrease the probability and severity of relapse for those in addiction recovery. MBRP incorporates components from CBT relapse prevention and includes training in meditation practices as a means to foster increased awareness of emotional and cognitive experiences. MBRP also includes training in brief informal meditations aimed at increasing awareness and adaptive response to drug cues and negative affect.

BEHAVIORAL

Treatment-As-Usual

Standard treatment programming procedures for all individuals residing within the residential treatment program. Includes: supportive group therapy; Narcotics Anonymous/12-Step Programming; music, art, and animal therapy; psycho-education on general issues related to mental health and SUDs; and medication counseling.

Trial Locations (1)

19382

Gaudenzia, Inc. (West Chester House), West Chester

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

West Chester University of Pennsylvania

OTHER

NCT05042388 - Mindfulness-Based Relapse Prevention to Improve Medication Assisted Treatment Adherence and Drug-use Outcomes for Opioid Use Disorder | Biotech Hunter | Biotech Hunter